Michael Prosser

Chief Business Officer at Crown Bioscience

Michael Prosser leads CrownBio’s Commercial and Strategic Development Division leveraging extensive experience in contract research and international pharmaceutical drug development. Prior to this Michael oversaw the establishment of CrownBio’s initial presence and growth in Europe, before taking on the general management of CrownBio’s sites in both the UK and San Diego, USA, leading the integration of both acquired subsidiaries.

Prior to joining CrownBio, Michael held a number of roles building global business development and product management teams. This includes with Accelera (the preclinical CRO of Nerviano Medical Sciences), MDS Pharma Services, and SNBL USA, Ltd. Michael also managed the International Affairs group at SNBL USA’s parent company, Shin Nippon Biomedical Laboratories (SNBL) in Kagoshima, Japan, and worked as a bench scientist at Eisai Pharmaceuticals in London.

Michael earned an M.Sc. in Applied Molecular Biology and Biotechnology from University College London, and a B.Sc. degree in Pharmacology from the University of Dundee.

Links

Previous companies

Timeline

  • Chief Business Officer

    May, 2022 - present

  • SVP, Commercial and Strategic Development

View in org chart